| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |